Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Glaucoma
MedTech
Alcon snags Belkin Vision's automated laser glaucoma therapy
The deal includes an upfront transfer of $81 million, including about $65 million in cash—plus up to $385 million more in sales-based milestones.
Conor Hale
Jul 3, 2024 4:25pm
Skye ends eye disease R&D after glaucoma drug's phase 2 fail
Jun 10, 2024 8:51am
Could an Alzheimer's-linked gene be key to stymying glaucoma?
Aug 17, 2022 3:20pm
Glaukos nets FDA OK for pressure-relieving glaucoma eye stent
Aug 4, 2022 12:36pm
AbbVie eyes $60M investment in glaucoma surgical devicemaker
Jul 20, 2022 11:15am
How a smart contact lens could deliver glaucoma drugs on demand
May 17, 2022 11:23am
